256 related articles for article (PubMed ID: 26683516)
21. Investigating kidney donation as a risk factor for hypertension and microalbuminuria: findings from the Swiss prospective follow-up of living kidney donors.
Thiel GT; Nolte C; Tsinalis D; Steiger J; Bachmann LM
BMJ Open; 2016 Mar; 6(3):e010869. PubMed ID: 27006347
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes of living kidney donors over the past 28 years in a single center in Taiwan.
Tsai SF; Shu KH; Ho HC; Wu MJ; Cheng CH; Lian JD; Wen MC; Su CK; Yu TM; Chuang YW; Huang ST; Chen CH
Transplant Proc; 2012 Jan; 44(1):39-42. PubMed ID: 22310573
[TBL] [Abstract][Full Text] [Related]
23. Long-term medical risks to the living kidney donor.
Lam NN; Lentine KL; Levey AS; Kasiske BL; Garg AX
Nat Rev Nephrol; 2015 Jul; 11(7):411-9. PubMed ID: 25941060
[TBL] [Abstract][Full Text] [Related]
24. Cystatin-C is associated with partial recovery of kidney function and progression to chronic kidney disease in living kidney donors: Observational study.
Bang JY; Kim SO; Kim SG; Song JG; Hwang GS
Medicine (Baltimore); 2017 Feb; 96(5):e6037. PubMed ID: 28151912
[TBL] [Abstract][Full Text] [Related]
25. Compensatory Hypertrophy After Living Donor Nephrectomy.
Chen KW; Wu MW; Chen Z; Tai BC; Goh YS; Lata R; Vathsala A; Tiong HY
Transplant Proc; 2016 Apr; 48(3):716-9. PubMed ID: 27234720
[TBL] [Abstract][Full Text] [Related]
26. Clinical assessment of renal function stabilization after living donor nephrectomy.
Choi KH; Yang SC; Joo DJ; Kim MS; Kim YS; Kim SI; Han WK
Transplant Proc; 2012 Dec; 44(10):2906-9. PubMed ID: 23194994
[TBL] [Abstract][Full Text] [Related]
27. Comparative outcomes of open nephrectomy, hand-assisted laparoscopic nephrectomy, and full laparoscopic nephrectomy for living donors.
Ungbhakorn P; Kongchareonsombat W; Leenanupan C; Kijvikai K; Wisetsingh W; Patcharatrakul S; Jirasiritam S
Transplant Proc; 2012 Jan; 44(1):22-5. PubMed ID: 22310568
[TBL] [Abstract][Full Text] [Related]
28. Early and late residual renal function and surgical complications in living donors: a 15-year experience at a single institution.
Sansalone CV; Maione G; Aseni P; Rossetti O; Mangoni I; Soldano S; De Roberto A; Minetti ME; Perrino ML; Civati G
Transplant Proc; 2006 May; 38(4):994-5. PubMed ID: 16757241
[TBL] [Abstract][Full Text] [Related]
29. Outcome of Live-Donor Renal Transplants With Incidentally Diagnosed Renal Angiomyolipoma in the Donor.
Zahran MH; Kamal AI; Abdelfattah A; Mashaly ME; Fakhreldin I; Osman Y; Ali-El-Dein B
Transplant Proc; 2019; 51(6):1773-1778. PubMed ID: 31255355
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease.
Muzaale AD; Massie AB; Kucirka LM; Luo X; Kumar K; Brown RS; Anjum S; Montgomery RA; Lentine KL; Segev DL
Transplantation; 2016 Jun; 100(6):1306-12. PubMed ID: 26457599
[TBL] [Abstract][Full Text] [Related]
31. Obesity and Loss of Kidney Function: Two Complications to Face for Older Living Kidney Donors.
Firat Kaya D; Sayin B; Saglam H; Gurlek Demirci B; Colak T
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):136-138. PubMed ID: 28260454
[TBL] [Abstract][Full Text] [Related]
32. Older living donors provide excellent quality kidneys: a single center experience (older living donors).
Johnson SR; Khwaja K; Pavlakis M; Monaco AP; Hanto DW
Clin Transplant; 2005 Oct; 19(5):600-6. PubMed ID: 16146550
[TBL] [Abstract][Full Text] [Related]
33. What is the significance of end-stage renal disease risk estimation in living kidney donors?
Gaillard F; Baron S; Timsit MO; Eladari D; Fournier C; Prot-Bertoye C; Bertocchio JP; Lamhaut L; Friedlander G; Méjean A; Legendre C; Courbebaisse M
Transpl Int; 2017 Aug; 30(8):799-806. PubMed ID: 28152216
[TBL] [Abstract][Full Text] [Related]
34. Living kidney donors developing end-stage renal disease.
Fehrman-Ekholm I; Nordén G; Lennerling A; Rizell M; Herlitz H; Nielsen FD; Storkamp O; Deurell SI; Olausson M
Transplant Proc; 2006 Oct; 38(8):2642-3. PubMed ID: 17098025
[TBL] [Abstract][Full Text] [Related]
35. Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.
Habbous S; Sarma S; Barnieh LJ; McArthur E; Klarenbach S; Manns B; Begen MA; Lentine KL; Garg AX;
Transplantation; 2018 Aug; 102(8):1367-1374. PubMed ID: 30044364
[TBL] [Abstract][Full Text] [Related]
36. Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.
Lentine KL; Lam NN; Segev DL
Clin J Am Soc Nephrol; 2019 Apr; 14(4):597-608. PubMed ID: 30858158
[TBL] [Abstract][Full Text] [Related]
37. Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer.
Vergho D; Burger M; Schrammel M; Brookman-May S; Gierth M; Hoschke B; Lopau K; Gilfrich C; Riedmiller H; Wolff I; May M
World J Urol; 2015 May; 33(5):725-31. PubMed ID: 25344313
[TBL] [Abstract][Full Text] [Related]
38. Onset of Hypertension in Living Kidney Donors After Donor Nephrectomy: Our 20 Years of Experience.
Tatar E; Karataş M; Kılıç M; Tercan IC; Okut G; Usoğlu B; Aykas A; Uslu A
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):156-158. PubMed ID: 30777544
[TBL] [Abstract][Full Text] [Related]
39. Postdonation Anemia in Living Kidney Donors.
Shah S; Lankowsky B; Gao T; Zaky Z; Stephany BR; Poggio ED
Transplant Proc; 2017 Oct; 49(8):1733-1738. PubMed ID: 28923617
[TBL] [Abstract][Full Text] [Related]
40. Kidney transplant outcomes for prior living organ donors.
Potluri V; Harhay MN; Wilson FP; Bloom RD; Reese PP
J Am Soc Nephrol; 2015 May; 26(5):1188-94. PubMed ID: 25412818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
